Biomedical Engineering Tissue Engineering

🔬 A New Era in Medicine: First-Ever 3D-Printed Windpipe Implanted in Cancer Survivor In a groundbreaking medical achievement, South Korean scientists have successfully implanted a 3D-printed trachea (windpipe) into a patient — marking a world-first and redefining the future of regenerative medicine. The patient, a woman who had lost a part of her windpipe due to thyroid cancer surgery, became the recipient of this bioengineered miracle. The artificial trachea was developed using bio-ink composed of the patient's own living cells — including cartilage and mucosal cells — combined with a biodegradable polymer scaffold (PCL). This scaffold not only provided mechanical strength but also allowed the body to regenerate its own tissue around it. What makes this even more astonishing? ✅ No immunosuppressants were needed. Since the trachea was built from the patient’s own cells, her body accepted it naturally. ✅ Healthy blood vessels formed within 6 months, a critical sign of integration and healing. ✅ The patient regained normal function without the usual complications of transplant rejection. Led by Seoul St. Mary’s Hospital and T&R Biofab, this achievement is being hailed as a major milestone in personalized medicine and bioprinting technology. The future is no longer dependent solely on donors — it's now being printed, cell by cell. This opens the door for the possibility of 3D-printed lungs, kidneys, even hearts — tailored for the individual, reducing waitlists, and eliminating the risk of rejection. We are witnessing the dawn of a medical revolution where organs won’t just be donated… they’ll be designed. #RegenerativeMedicine #3DPrinting #HealthcareInnovation #Biotech #FutureOfMedicine #MedicalBreakthrough #OrganTransplant 🪻Ram Sharma 🪻

Researchers have successfully 3D printed a cornea to restore sight. Scientists at Pohang University of Science and Technology and Kyungpook National University have achieved a major milestone in regenerative medicine by 3D printing an artificial cornea. Using a specialized "bioink" derived from decellularized corneal stroma and stem cells, the team successfully replicated the complex collagen lattice essential for human vision. Unlike previous attempts with synthetic materials, this bioprinted tissue maintains the exact transparency and flexibility required for the eye to function naturally, offering a potential solution for the global shortage of donor corneas. The success of this innovation lies in the team's ability to regulate "shear stress" during the printing process. This technique allows for the precise alignment of collagen fibrils, mimicking the native architectural pattern of a human cornea—a feat previously thought impossible. By creating a biocompatible environment that supports cellular growth and optical clarity, this research marks a significant leap forward in bioengineering. This development could eventually reduce the risk of transplant rejection and provide millions of patients with a life-changing alternative to traditional grafts. source: Kim, J. H., Kim, K. W., Yun, J. W., & Cho, D. W. Shear-induced alignment of collagen fibrils using 3D cell printing for corneal stroma tissue engineering. Biofabrication.

German scientists have created a tiny 3D printer that can build living tissue inside the human body. The system uses a microscopic lens smaller than a grain of salt, attached to an optical fiber, to guide light and solidify bioinks into precise structures. Unlike most conventional bioprinters that operate outside the body, this device can be inserted through an endoscope, enabling direct, minimally invasive tissue fabrication. By printing cells and biodegradable materials exactly where they are needed—rather than growing tissue externally and transplanting it later—researchers can potentially repair or rebuild damaged organs with unprecedented precision. The technology’s micrometer-scale accuracy opens the door to in-body printing of vascular structures, cartilage, or even neural tissue, marking a step toward true on-demand organ repair.

A milestone in regenerative medicine just moved organ transplantation closer to reality. Researchers at Tel Aviv University have successfully 3D-printed the world’s first vascularized heart using a patient’s own cells and biological materials a breakthrough that reshapes what’s possible in cardiovascular care. Unlike earlier models that relied on empty scaffolds or lacked living tissue, this miniature heart contains cardiac muscle cells, blood vessels, and chambers, organized in the complex architecture required for heart function. The innovation lies in the material: a personalized bio-ink created from the patient’s own fatty tissue, reprogrammed into stem cells and differentiated into heart and vascular cells. Because the tissue is biologically matched, the risk of immune rejection is dramatically reduced. While the heart is not yet capable of pumping blood or sustaining high-pressure circulation, this achievement represents a critical proof-of-concept. It demonstrates that fully cellular, patient-specific organs can be printed not just modeled. Why this matters: • Organ donor shortages remain one of the greatest barriers in modern medicine • Thousands die each year waiting for heart transplants • Personalized, lab-grown organs could eliminate rejection and lifelong immunosuppression The long-term vision is profound: hospitals printing functional human hearts on demand, tailored to each patient’s biology. Significant challenges remain cell synchronization, electrical conduction, mechanical strength but the foundation has been laid. This is not science fiction. It is the early architecture of a new medical era one where regeneration replaces replacement, and precision biology reshapes survival itself. Source: Freeman, D. Scientists create world’s first 3D-printed heart using human cells. NBC News MACH #MatriarchHealth #RegenerativeMedicine #3DPrinting #CardiovascularScience #FutureOfMedicine #Biotechnology #OrganTransplant #MedicalInnovation #ScienceBacke

The agonizing and scarring process of traditional skin grafting for burn victims is being rendered obsolete by the convergence of robotics and regenerative medicine. 🩹 Researchers at the Wake Forest Institute for Regenerative Medicine in the United States have successfully advanced their mobile, in-situ 3D skin bioprinter into highly successful clinical applications. Instead of harvesting large, painful sections of healthy skin from elsewhere on a patient’s body, this specialized machine literally prints a customized layer of new living tissue directly onto the injury. The device resembles a highly sophisticated, multi-axis robotic arm mounted on a cart that can be rolled right up to a hospital bed. The machine first uses an integrated laser scanner to map the exact topography, depth, and size of the wound with microscopic accuracy. Once the geometry is mapped, the printer utilizes a sterile "bio-ink" consisting of the patient's own isolated skin cells suspended in a healing hydrogel, depositing them layer by layer precisely where they are needed to replicate the dermis and epidermis. In early 2026, this technology has demonstrated a profound ability to accelerate the healing process of severe, extensive burns while virtually eliminating donor-site morbidity and scarring. By combining digital 3D mapping with living biological material, this breakthrough allows the human body to regenerate its largest organ smoothly, setting a new global standard for trauma care. - News Source: Science Translational Medicine / Wake Forest – "In-Situ 3D Bioprinter Demonstrates Rapid Healing in Clinical Burn Trauma Applications" (2025/2026) -

Cells do the visible work in wound healing—but who gives the orders? Who tells them when to move, what to do, and when to stop? Growth factors: Tiny messengers. These signaling molecules are released in a precise sequence, guiding each phase of healing like conductors in a biological orchestra. Let’s meet the key players—and some underrated ones too Hemostasis & Inflammation: The Alarms and Recruitment Signals 1️⃣ PDGF (Platelet-Derived Growth Factor) 🔹 From platelets—first to arrive 🔹 Recruits neutrophils, macrophages, and fibroblasts 2️⃣ TGF-β (Transforming Growth Factor-beta) 🔹 Stimulates ECM production 🔹 Encourages macrophage transition from M1 (fighters) to M2 (healers) 3️⃣ IL-1 & TNF-α 🔹 Spark the initial inflammatory response 🔹 Help immune cells infiltrate the wound 4️⃣ MCP-1 & GM-CSF 🔹 Act as megaphones—summoning more monocytes 🔹 Support macrophage and neutrophil activation These growth factors are like 911 dispatchers and emergency field commanders sending out the radio call: “We’ve got damage—send in the cleanup and construction crews.” Proliferation: The Builders and Plumbers at Work 5️⃣ VEGF (Vascular Endothelial Growth Factor) 🔹 Fuels angiogenesis—new blood vessel formation 🔹 Ensures oxygen + nutrients reach the rebuilding zone 6️⃣ EGF (Epidermal Growth Factor) 🔹 Stimulates keratinocytes to close the wound 🔹 Supports fibroblast growth 7️⃣ FGF (Fibroblast Growth Factor) 🔹 Boosts fibroblast proliferation 🔹 Helps endothelial cells form stable capillaries 8️⃣ IGF-1 (Insulin-like Growth Factor 1) 🔹 Enhances fibroblast & keratinocyte survival and division 🔹 Promotes collagen production 9️⃣ KGF (Keratinocyte Growth Factor / FGF-7) 🔹 A specialist in re-epithelialization 🔹 Speeds up keratinocyte migration 🔟 Angiopoietins (Ang-1 & Ang-2) 🔹 Work with VEGF 🔹 Ang-1 stabilizes vessels; Ang-2 loosens them for remodeling Think of this phase like a well-run construction site. Growth factors act as foremen—coordinating cell crews, allocating resources, and pushing the project forward. Remodeling: The Quality Control Team 🔁 TGF-β (again!) 🔹 Orchestrates ECM remodeling 🔹 Switches collagen III → collagen I 🔹 Activates myofibroblasts to close the wound 🔁 CTGF (Connective Tissue Growth Factor) 🔹 Supports long-term tissue strength 🔹 Key in collagen crosslinking and fibrosis regulation 🔁 MMPs (Matrix Metalloproteinases) 🔹 Not growth factors, but crucial downstream targets 🔹 Break down old ECM—clearing space for new tissue 🔹 Balanced by TIMPs (Tissue Inhibitors of MMPs) This phase is less about building and more about refining—aligning fibers, closing gaps, and reinforcing what’s already built. Understanding these molecular conductors helps us design smarter wound therapies—not just by stimulating cells, but by guiding their behavior strategically. Because behind every healing cell… there’s a growth factor whispering directions.

South Korea printed living skin with blood vessels — that grafts perfectly onto burn victims 🩹 South Korean bioengineers at POSTECH have 3D-printed functional human skin complete with working blood vessels, sweat glands, and hair follicles. The bioprinted skin integrates seamlessly with patients' own tissue, representing the holy grail of regenerative medicine for burn victims and trauma patients. The technology layers living cells in bioink: Keratinocytes form the protective outer layer Fibroblasts create connective tissue Endothelial cells form capillaries Melanocytes provide pigmentation Most remarkably, the printed blood vessels connect with the patient's circulatory system within 48 hours, ensuring the grafted skin receives nutrients and stays alive. Traditional skin grafts often fail due to poor vascularization — this solves that fundamental problem. Clinical trials show: 95% graft survival rate Faster healing than conventional grafts Natural appearance and function Reduced scarring For 180,000 annual burn deaths globally and millions more with severe scarring, this technology offers hope for complete restoration. The next frontier: printing skin with nerve endings for full sensation recovery. Source: POSTECH Department of Bioengineering, Science Translational Medicine 2025 #RegenerativeMedicine #3DPrinting #SouthKorea #BurnTreatment #Biotechnology #TissueEngineering #MedicalInnovation #SkinGrafts #Bioprinting #FutureMedicine #drkevinramdhun

We developed not only a new 3D bioprinting platform that can create many tiny, cell-containing tissue models at once, but also a system in which these hydrogels remain fully immersed in compartmentalized droplets after printing—reducing both fabrication and application time from hours to minutes. Sequential fabrication remains a major bottleneck in scaling 3D bioprinting for disease modeling and drug discovery, forcing a trade‑off between physiological relevance and throughput. In our new Advanced Functional Materials paper, we introduce a platform for fully parallel 3D bioprinting of cell‑laden hydrogel arrays on a wall‑less liquid compartmentalization system. By integrating DLP stereolithography with a slippery liquid‑infused Droplet Microarray (SLIPS‑DMA), fabrication time is decoupled from array size. Tens to hundreds of cell‑containing 3D hydrogel constructs with defined geometries can be printed simultaneously, in minutes, fully immersed in compartmentalized droplets while preserving shape fidelity and cell viability. This establishes a scalable system‑on‑a‑chip for multiplexed screening of cell–material–drug interactions, overcoming a long‑standing throughput limitation in 3D biofabrication. Paper: https://lnkd.in/exfM4tcy